A recent study indicates that people who come off new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt traditional lifestyle programs.
Findings released in a prominent health publication points out that while obese people can lose about a fifth of their body weight while on the medication, the weight is regained at an average rate of 0.8 kg per month after stopping.
"Individuals purchasing such treatments must be cognizant of the potential of quick weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of regain implies a reversion to original weight in about a year and a half.
Weighing Approaches
The research, which reviewed 37 of studies involving over 9,000 of participants, contrasted the effects of GLP-1 agonists with conventional dieting.
Researchers point out that people who shed pounds through lifestyle changes alone generally have a more gradual creep back—approximately 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Nutrition scientists propose the mechanism of the injections explains the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal could lead to the system to produce less of its endogenous hormone, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating a significant risk."
An Ongoing Condition?
Medical guidelines advise the jabs for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts say that, considering the high risk of relapse, the treatment might need to be life-long.
This view is reinforced by drug manufacturers, who note that the findings "emphasize the chronic character of excess weight," similar to managing diseases like diabetes.
Patient Testimonies
Users who have stopped the medication explain a intense return of hunger.
"It felt as if something flipping and you become ravenous," described a patient.
This difficulty is compounded if users have not developed lasting dietary or behavioural modifications during treatment.
Significant Adoption
Survey data suggest that a significant number of people in the UK have tried these injections in the last 12 months, with interest being substantial.
- Use is higher among women than men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers caution that while the jabs are powerful agents for shedding pounds, they are not a permanent solution and lasting health benefits hinges on combined lifestyle changes.
